STOCK TITAN

Columbia Financial (CLBK) director boosts deferred stock stake

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Columbia Financial, Inc. director Noel R. Holland reported a small acquisition of phantom stock tied to company shares. On January 23, 2026, a trustee for the bank’s rabbi trust purchased 10.7115 phantom stock units at $15.91 each under the Columbia Bank Stock Based Deferral Plan, bringing Holland’s beneficial interest in that plan to 10,011.7382 units, which will be settled in stock at distribution.

Holland also reports holding 33,519 shares of common stock directly, 46,280 shares indirectly through a SEP-IRA, and 3,207 shares through a stock award granted under the 2019 Equity Incentive Plan that vests on March 11, 2026. In addition, Holland holds 83,294 stock options with a $15.60 exercise price, fully vested and exercisable until July 23, 2029.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Holland Noel R.

(Last) (First) (Middle)
19-01 ROUTE 208 NORTH

(Street)
FAIR LAWN NJ 07410

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Columbia Financial, Inc. [ CLBK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
01/23/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 01/23/2026 A 10.7115(1) A $15.91 10,011.7382 I By Stock-Based Deferral Plan
Common Stock 33,519 D
Common Stock 46,280 I By SEP-IRA
Common Stock 3,207 I By Stock Award IV(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (right to buy) $15.6 07/23/2020(3) 07/23/2029 Common Stock 83,294 83,294 D
Explanation of Responses:
1. Represents phantom stock purchased, on a non-discretionary basis, by the trustee of the Bank's rabbi trust maintained in connection with the Columbia Bank Stock Based Deferral Plan, a non-qualified stock-based deferral plan. Stock unit interests under the Columbia Bank Stock Based Deferral Plan will be settled in shares of stock upon distribution to the reporting person.
2. Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan which vest in one year on March 11, 2026.
3. Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan are fully vested and exercisable.
Remarks:
/s/ Dennis E. Gibney, Power of Attorney 01/27/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did CLBK director Noel R. Holland report?

Director Noel R. Holland reported an acquisition of 10.7115 phantom stock units on January 23, 2026, tied to Columbia Financial, Inc. common stock.

At what price were the Columbia Financial (CLBK) phantom stock units acquired?

The phantom stock units were purchased at a price of $15.91 per unit in connection with Columbia Financial, Inc. common stock.

What is the nature of Noel R. Holland’s phantom stock under the Columbia Bank deferral plan?

The phantom stock was purchased on a non-discretionary basis by the trustee of the bank’s rabbi trust under the Columbia Bank Stock Based Deferral Plan, a non-qualified stock-based deferral plan. These stock unit interests will be settled in shares of stock when distributed to Holland.

How many Columbia Financial shares does Noel R. Holland report holding directly and indirectly?

Holland reports 33,519 shares of common stock directly, 46,280 shares indirectly through a SEP-IRA, and 3,207 shares indirectly via a stock award, in addition to 10,011.7382 phantom stock units in the deferral plan.

What stock options in CLBK does Noel R. Holland beneficially own?

Holland holds 83,294 stock options (right to buy) Columbia Financial common shares with an exercise price of $15.60. These options are fully vested and exercisable and expire on July 23, 2029.

When do Noel R. Holland’s Columbia Financial stock awards vest?

The reported stock awards were granted under the Columbia Financial, Inc. 2019 Equity Incentive Plan and vest in one year on March 11, 2026.

Columbia Financ

NASDAQ:CLBK

CLBK Rankings

CLBK Latest News

CLBK Latest SEC Filings

CLBK Stock Data

1.66B
26.22M
74.42%
13.11%
1.5%
Banks - Regional
Savings Institution, Federally Chartered
Link
United States
FAIR LAWN